An AAV Gene Therapy Trial of AFTX-201 in Adults With BAG3-Associated Dilated Cardiomyopathy (DCM)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Dilated Cardiomyopathy (DCM) · BAG3 Mutation Associated Dilated Cardiomyopathy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Miami Hospital and Clinics, Miami, Florida, United States
Contact: Study coordinator (Lina Carceres) · caceresl@miami.edu · 954 249 3587
St. Lukes Hospital, Kansas City, Missouri, United States
Contact: Study coordinator (Amanda Huffman, RN, BSN) · amanda.huffman@bjc.org · 816-932-0391
Houston Methodist Hospital, Houston, Texas, United States
Contact: Study coordinator (Jennifer (Garrett) Medley Sr. Clinical Trials Manager) · jmgarrett@houstonmethodist.org · 346-238-4516

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Outcome-targeted Therapy: Principle and Outcome Evaluation: Clinical Study and Phenotype-genotype Correlation

Dilated Cardiomyopathy

Abroad (travel likely)RecruitingPHASE2

Taipei County, Taiwan

A Study of AZD4063 in PLN R14del Dilated Cardiomyopathy

Dilated Cardiomyopathy

Abroad (travel likely)RecruitingPHASE1

Amsterdam, Netherlands · Groningen, Netherlands

A Phase 1 Open-Label Study of the Safety of Intravenous Allogeneic Neonatal Mesenchymal Cells (nMSCs) in Young Adult (1A) and Pediatric (1B) Patients With Dilated Cardiomyopathy (DCM)

Dilated Cardiomyopathy

Abroad (travel likely)RecruitingPHASE1

Atlanta, United States · Atlanta, United States

Pediatric Cardiomyopathy Mutation Analysis

Cardiomyopathies · Dilated Cardiomyopathy · Hypertrophic Cardiomyopathy

Abroad (travel likely)Recruiting

Indianapolis, United States